(VIV) Vivendi - Overview
Stock: Games, Music, Betting, Connectivity, Content
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.53% |
| Yield on Cost 5y | 0.79% |
| Yield CAGR 5y | -49.19% |
| Payout Consistency | 77.7% |
| Payout Ratio | 65.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 27.7% |
| Relative Tail Risk | -12.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.81 |
| Alpha | -28.41 |
| Character TTM | |
|---|---|
| Beta | 0.130 |
| Beta Downside | 0.495 |
| Drawdowns 3y | |
|---|---|
| Max DD | 65.70% |
| CAGR/Max DD | -0.38 |
Description: VIV Vivendi January 12, 2026
Vivendi SE is a diversified French media conglomerate that operates across content creation, distribution, and digital services. Its portfolio spans video games (mobile, PC, console), recorded music and publishing, audio-visual production, online sports betting, fixed-line and mobile connectivity, and multilingual news and entertainment for Spanish- and Portuguese-speaking audiences. The group also has activities in publishing, travel-retail, television, and broader digital media, and is headquartered in Paris.
Key recent metrics highlight the scale and financial profile of the business: FY 2023 revenue reached €53.5 bn, with an adjusted EBITDA margin of roughly 10 % and free cash flow of €3.5 bn. The company’s net debt stood at €30 bn, giving a debt-to-EBITDA ratio near 1.2×, which is modest for a media-heavy balance sheet. Growth drivers include the continued expansion of mobile gaming (Gameloft’s Q4 2023 MAU growth of 12 %), the resurgence of advertising spend in Europe, and the regulatory-driven upside in online sports betting markets, while downside risk stems from currency exposure and potential tightening of media-ownership rules in the EU.
For a data-rich, model-ready deep-dive on Vivendi’s valuation and scenario analysis, the ValueRay profile is a useful next stop.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: -6.05b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA -3.04 > 1.0 |
| NWC/Revenue: -7.39% < 20% (prev -29.05%; Δ 21.66% < -1%) |
| CFO/TA 0.24 > 3% & CFO 1.78b > Net Income -6.05b |
| Net Debt (1.82b) to EBITDA (371.0m): 4.91 < 3 |
| Current Ratio: 0.51 > 1.5 & < 3 |
| Outstanding Shares: last quarter (996.1m) vs 12m ago -2.54% < -2% |
| Gross Margin: 48.32% > 18% (prev 0.47%; Δ 4785 % > 0.5%) |
| Asset Turnover: 20.10% > 50% (prev 32.41%; Δ -12.31% > 0%) |
| Interest Coverage Ratio: -2.40 > 6 (EBITDA TTM 371.0m / Interest Expense TTM 211.0m) |
Altman Z'' 3.05
| A: -0.05 (Total Current Assets 363.0m - Total Current Liabilities 708.0m) / Total Assets 7.33b |
| B: 0.52 (Retained Earnings 3.79b / Total Assets 7.33b) |
| C: -0.02 (EBIT TTM -507.0m / Avg Total Assets 23.24b) |
| D: 1.74 (Book Value of Equity 4.36b / Total Liabilities 2.51b) |
| Altman-Z'' Score: 3.05 = A |
Beneish M -4.00
| DSRI: 0.04 (Receivables 97.0m/6.19b, Revenue 4.67b/12.69b) |
| GMI: 0.97 (GM 48.32% / 46.89%) |
| AQI: 1.49 (AQ_t 0.94 / AQ_t-1 0.63) |
| SGI: 0.37 (Revenue 4.67b / 12.69b) |
| TATA: -1.07 (NI -6.05b - CFO 1.78b) / TA 7.33b) |
| Beneish M-Score: -5.10 (Cap -4..+1) = AAA |
What is the price of VIV shares?
Over the past week, the price has changed by -5.30%, over one month by -5.98%, over three months by -25.51% and over the past year by -21.13%.
Is VIV a buy, sell or hold?
What are the forecasts/targets for the VIV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 3.6 | 61.3% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 2 | -12.2% |
VIV Fundamental Data Overview February 02, 2026
P/E Forward = 10.8696
P/S = 7.6049
P/B = 0.4861
P/EG = 1.6331
Revenue TTM = 4.67b EUR
EBIT TTM = -507.0m EUR
EBITDA TTM = 371.0m EUR
Long Term Debt = 1.50b EUR (from longTermDebt, last quarter)
Short Term Debt = 474.0m EUR (from shortTermDebt, last quarter)
Debt = 1.99b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.82b EUR (from netDebt column, last quarter)
Enterprise Value = 4.93b EUR (3.10b + Debt 1.99b - CCE 167.0m)
Interest Coverage Ratio = -2.40 (Ebit TTM -507.0m / Interest Expense TTM 211.0m)
EV/FCF = -74.66x (Enterprise Value 4.93b / FCF TTM -66.0m)
FCF Yield = -1.34% (FCF TTM -66.0m / Enterprise Value 4.93b)
FCF Margin = -1.41% (FCF TTM -66.0m / Revenue TTM 4.67b)
Net Margin = -129.6% (Net Income TTM -6.05b / Revenue TTM 4.67b)
Gross Margin = 48.32% ((Revenue TTM 4.67b - Cost of Revenue TTM 2.41b) / Revenue TTM)
Gross Margin QoQ = 30.34% (prev 30.34%)
Tobins Q-Ratio = 0.67 (Enterprise Value 4.93b / Total Assets 7.33b)
Interest Expense / Debt = 3.11% (Interest Expense 62.0m / Debt 1.99b)
Taxrate = 14.29% (2.50m / 17.5m)
NOPAT = -434.6m (EBIT -507.0m * (1 - 14.29%)) [loss with tax shield]
Current Ratio = 0.51 (Total Current Assets 363.0m / Total Current Liabilities 708.0m)
Debt / Equity = 0.41 (Debt 1.99b / totalStockholderEquity, last quarter 4.82b)
Debt / EBITDA = 4.91 (Net Debt 1.82b / EBITDA 371.0m)
Debt / FCF = -27.59 (negative FCF - burning cash) (Net Debt 1.82b / FCF TTM -66.0m)
Total Stockholder Equity = 4.70b (last 4 quarters mean from totalStockholderEquity)
RoA = -26.05% (Net Income -6.05b / Total Assets 7.33b)
RoE = -128.7% (Net Income TTM -6.05b / Total Stockholder Equity 4.70b)
RoCE = -8.18% (EBIT -507.0m / Capital Employed (Equity 4.70b + L.T.Debt 1.50b))
RoIC = -6.21% (negative operating profit) (NOPAT -434.6m / Invested Capital 7.00b)
WACC = 4.94% (E(3.10b)/V(5.09b) * Re(6.40%) + D(1.99b)/V(5.09b) * Rd(3.11%) * (1-Tc(0.14)))
Discount Rate = 6.40% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -4.97%
Fair Price DCF = unknown (Cash Flow -66.0m)
EPS Correlation: -14.06 | EPS CAGR: 141.5% | SUE: 0.0 | # QB: 0
Revenue Correlation: -55.88 | Revenue CAGR: -71.68% | SUE: 0.01 | # QB: 0
EPS next Year (2026-12-31): EPS=0.10 | Chg30d=-0.001 | Revisions Net=+0 | Growth EPS=+65.5% | Growth Revenue=+2.8%